BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19576173)

  • 21. Alpha-aminothiazole-gamma-aminobutanoic amides as potent, small molecule CCR2 receptor antagonists.
    Zhou C; Guo L; Parsons WH; Mills SG; MacCoss M; Vicario PP; Zweerink H; Cascieri MA; Springer MS; Yang L
    Bioorg Med Chem Lett; 2007 Jan; 17(2):309-14. PubMed ID: 17092717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. n-Nonanoyl-CCL14 (NNY-CCL14), a novel inhibitor of allergic airway inflammation is a partial agonist of human CCR2.
    Gupta S; Erdmann G; Schulz-Maronde S; Escher SE; Richter R; Forssmann WG; Elsner J; Forssmann U
    Allergy; 2008 Oct; 63(10):1317-23. PubMed ID: 18782110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2).
    Carter PH; Brown GD; Friedrich SR; Cherney RJ; Tebben AJ; Lo YC; Yang G; Jezak H; Solomon KA; Scherle PA; Decicco CP
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5455-61. PubMed ID: 17720492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies.
    Daly C; Rollins BJ
    Microcirculation; 2003 Jun; 10(3-4):247-57. PubMed ID: 12851642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of 3,5-bis(trifluoromethyl)benzyl L-arylglycinamide based potent CCR2 antagonists.
    Yang L; Zhou C; Guo L; Morriello G; Butora G; Pasternak A; Parsons WH; Mills SG; MacCoss M; Vicario PP; Zweerink H; Ayala JM; Goyal S; Hanlon WA; Cascieri MA; Springer MS
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3735-9. PubMed ID: 16698264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS).
    Zhang R; Gascon R; Miller RG; Gelinas DF; Mass J; Lancero M; Narvaez A; McGrath MS
    J Neuroimmunol; 2006 Oct; 179(1-2):87-93. PubMed ID: 16857270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokine receptor CCR2 undergoes transportin1-dependent nuclear translocation.
    Favre N; Camps M; Arod C; Chabert C; Rommel C; Pasquali C
    Proteomics; 2008 Nov; 8(21):4560-76. PubMed ID: 18846510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion.
    Furlan F; Orlando S; Laudanna C; Resnati M; Basso V; Blasi F; Mondino A
    J Cell Sci; 2004 Jun; 117(Pt 14):2909-16. PubMed ID: 15173320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological characterization of human monocyte chemoattractant protein 1 (MCP-1) and its analogs.
    Kruszynski M; Stowell N; Das A; Seideman J; Tsui P; Brigham-Burke M; Nemeth JF; Sweet R; Heavner GA
    J Pept Sci; 2006 Jan; 12(1):25-32. PubMed ID: 15942931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental study on simvastatin in prevention and treatment of aseptic loosening of prosthesis].
    Wang Z; Gao X; Sun K; Jin Q
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 May; 24(5):544-7. PubMed ID: 20540256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the angiogenesis by the MCP-1 (monocyte chemoattractant protein-1) binding peptide.
    Kim MY; Byeon CW; Hong KH; Han KH; Jeong S
    FEBS Lett; 2005 Mar; 579(7):1597-601. PubMed ID: 15757647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmin induces in vivo monocyte recruitment through protease-activated receptor-1-, MEK/ERK-, and CCR2-mediated signaling.
    Carmo AA; Costa BR; Vago JP; de Oliveira LC; Tavares LP; Nogueira CR; Ribeiro AL; Garcia CC; Barbosa AS; Brasil BS; Dusse LM; Barcelos LS; Bonjardim CA; Teixeira MM; Sousa LP
    J Immunol; 2014 Oct; 193(7):3654-63. PubMed ID: 25165151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocyte chemoattractant protein-1 (MCP-1) produced via NF-kappaB signaling pathway mediates migration of amoeboid microglia in the periventricular white matter in hypoxic neonatal rats.
    Deng YY; Lu J; Ling EA; Kaur C
    Glia; 2009 Apr; 57(6):604-21. PubMed ID: 18942743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Brogan JB; Mo R; Lo YC; Yang G; Miller PB; Scherle PA; Molino BF; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2009 Feb; 19(3):597-601. PubMed ID: 19131247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The obesity and inflammatory marker haptoglobin attracts monocytes via interaction with chemokine (C-C motif) receptor 2 (CCR2).
    Maffei M; Funicello M; Vottari T; Gamucci O; Costa M; Lisi S; Viegi A; Ciampi O; Bardi G; Vitti P; Pinchera A; Santini F
    BMC Biol; 2009 Dec; 7():87. PubMed ID: 20017911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MCP-1 promotes invasion and adhesion of human ovarian cancer cells.
    Furukawa S; Soeda S; Kiko Y; Suzuki O; Hashimoto Y; Watanabe T; Nishiyama H; Tasaki K; Hojo H; Abe M; Fujimori K
    Anticancer Res; 2013 Nov; 33(11):4785-90. PubMed ID: 24222114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small molecule antagonists of the CCR2b receptor. Part 2: Discovery process and initial structure-activity relationships of diamine derivatives.
    Moree WJ; Kataoka K; Ramirez-Weinhouse MM; Shiota T; Imai M; Sudo M; Tsutsumi T; Endo N; Muroga Y; Hada T; Tanaka H; Morita T; Greene J; Barnum D; Saunders J; Kato Y; Myers PL; Tarby CM
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5413-6. PubMed ID: 15454236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts.
    Marino M; Scuderi F; Provenzano C; Scheller J; Rose-John S; Bartoccioni E
    J Neuroimmunol; 2008 May; 196(1-2):41-8. PubMed ID: 18400310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of MCP-1/CCR2 signaling does not inhibit intimal proliferation in a mouse aortic transplant model.
    Alexis JD; Pyo RT; Chereshnev I; Katz J; Rollins BJ; Charo IF; Taubman MB
    J Vasc Res; 2008; 45(6):538-46. PubMed ID: 18463419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel, orally bioavailable gamma-aminoamide CC chemokine receptor 2 (CCR2) antagonists.
    Pasternak A; Marino D; Vicario PP; Ayala JM; Cascierri MA; Parsons W; Mills SG; Maccoss M; Yang L
    J Med Chem; 2006 Aug; 49(16):4801-4. PubMed ID: 16884289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.